PTC Therapeutics, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 99 29 31 23 37 83 194 265 307 381 539 699 938 807
Przychód Δ r/r 0.0% -70.9% 8.9% -26.7% 60.1% 124.9% 135.0% 36.2% 16.0% 24.0% 41.4% 29.7% 34.2% -14.0%
Marża brutto 100.0% 118.0% -75.2% -247.7% 100.0% 100.0% 97.6% 95.2% 96.0% 95.0% 94.0% 93.6% 69.3% 100.0%
EBIT (mln) 31 -27 -45 -99 -167 -132 -64 -116 -193 -398 -375 -440 -349 -303
EBIT Δ r/r 0.0% -187.7% 69.3% 119.0% 68.1% -21.0% -51.3% 79.9% 66.7% 106.4% -5.8% 17.3% -20.6% -13.4%
EBIT (%) 30.9% -93.2% -144.9% -432.9% -454.6% -159.7% -33.1% -43.7% -62.8% -104.5% -69.6% -63.0% -37.3% -37.5%
Koszty finansowe (mln) 0 0 0 1 -2 -8 -12 -13 -12 56 86 91 129 167
EBITDA (mln) 33 -24 -43 -99 -167 -132 -49 -54 -117 -228 -378 -373 -113 -120
EBITDA(%) 33.8% -83.8% -136.9% -432.9% -454.6% -159.7% -25.2% -20.4% -38.0% -59.8% -70.2% -53.3% -12.0% -14.9%
Podatek (mln) -2 1 6 -5 0 1 1 -0 12 35 6 -28 -70 0
Zysk Netto (mln) 31 -26 -52 -94 -170 -142 -79 -128 -252 -438 -524 -559 -627 -363
Zysk netto Δ r/r 0.0% -184.9% 96.6% 81.8% 81.8% -16.6% -44.4% 62.1% 96.4% 74.2% 19.6% 6.7% 12.1% -42.0%
Zysk netto (%) 31.2% -91.2% -164.6% -408.3% -463.6% -171.8% -40.6% -48.4% -82.0% -115.1% -97.3% -80.0% -66.8% -45.0%
EPS 0.0018 -1.85 -4.02 -2.97 -5.07 -4.17 -2.02 -2.75 -4.27 -6.64 -7.43 -7.79 -8.37 -4.73
EPS (rozwodnione) 0.0011 -1.11 -4.02 -2.97 -5.07 -4.17 -2.02 -2.75 -4.27 -6.64 -7.43 -7.79 -8.37 -4.73
Ilośc akcji (mln) 14 14 13 32 34 34 39 47 59 66 70 72 75 77
Ważona ilośc akcji (mln) 24 24 13 32 34 34 39 47 59 66 70 72 75 77
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD